These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 8419702)
1. Should adenosine continue to be ignored as a cardioprotective agent in cardiac operations? Galiñanes M; Chambers DJ; Hearse DJ J Thorac Cardiovasc Surg; 1993 Jan; 105(1):180-3. PubMed ID: 8419702 [No Abstract] [Full Text] [Related]
3. Role of adenosine as adjunctive therapy in acute myocardial infarction. Forman MB; Stone GW; Jackson EK Cardiovasc Drug Rev; 2006; 24(2):116-47. PubMed ID: 16961725 [TBL] [Abstract][Full Text] [Related]
7. Myocardial reperfusion injury. Forman MB; Jackson EK N Engl J Med; 2007 Dec; 357(23):2408; author reply 2409-10. PubMed ID: 18069133 [No Abstract] [Full Text] [Related]
8. Synergistic myoprotection of L-arginine and adenosine in a canine model of global myocardial ischaemic reperfusion injury. Du L; Dian K; Chen HJ; An Q; Jia MX; Yang PL; Wang W; Deng SZ; Liu J Chin Med J (Engl); 2007 Nov; 120(22):1975-81. PubMed ID: 18067781 [TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction. Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911 [TBL] [Abstract][Full Text] [Related]
10. Myocardial protection during heart surgery in China. Ji B; Liu J Chin Med J (Engl); 2007 Jan; 120(1):62-7. PubMed ID: 17254490 [No Abstract] [Full Text] [Related]
11. Past and present in myocardial protection. Takaba T; Inoue K Ann Thorac Cardiovasc Surg; 2000 Feb; 6(1):3-8. PubMed ID: 10748352 [TBL] [Abstract][Full Text] [Related]
12. [Study of no-reflow phenomenon after reperfusion for acute myocardial infarction]. Yang YJ; Zhao JL Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(31):2169-70. PubMed ID: 16321176 [No Abstract] [Full Text] [Related]
14. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs. Vander Heide RS; Reimer KA Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400 [TBL] [Abstract][Full Text] [Related]
15. Editorial overview: cardioprotective drugs for myocardial ischemic injury--a therapeutic area at risk. Knight DR Curr Opin Investig Drugs; 2007 Mar; 8(3):190-2. PubMed ID: 17408113 [No Abstract] [Full Text] [Related]
16. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies. Dirksen MT; Laarman GJ; Simoons ML; Duncker DJ Cardiovasc Res; 2007 Jun; 74(3):343-55. PubMed ID: 17306241 [TBL] [Abstract][Full Text] [Related]
17. Adenosine pretreatment of human myocardium and ischemic preconditioning. Lee HT Circulation; 1998 Jun; 97(22):2279. PubMed ID: 9631881 [No Abstract] [Full Text] [Related]
18. Anesthetic preconditioning: how important is it in today's cardiac anesthesia? De Hert SG J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):473-6. PubMed ID: 16884975 [No Abstract] [Full Text] [Related]
19. Thrombin in myocardial ischemia-reperfusion during cardiac surgery. Raivio P; Lassila R; Petäjä J Ann Thorac Surg; 2009 Jul; 88(1):318-25. PubMed ID: 19559265 [TBL] [Abstract][Full Text] [Related]
20. [Antiarrhythmic and cardioprotective effect of stimulation of delta1-opiate receptors in myocardial ischemia and reperfusion]. Lasukova TV; Krylatov AV; Maslov LN; Lishmanov IuB; Gross GJ; Podoksenov IuK; Podoksenov AIu Patol Fiziol Eksp Ter; 2004; (3):12-5. PubMed ID: 15446414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]